Lymphedema
Conditions
Interventions
This is an open, non-randomized, experimental, quantitative, longitudinal, and prospective clinical trial with a "pre- and post-intervention" design. The target sample size is 24 participants, all all
E02.760.169.063.500.387
E02.760.169.063.500.387.875
I03.350
Sponsors
Universidade do Estado de Mato Grosso - UNEMAT
Universidade do Estado de Mato Grosso - UNEMAT
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Women; aged 18 years or older; without cognitive alterations and able to understand the Informed Consent Form (ICF); diagnosed with breast cancer; undergoing treatment; capable of physical exercises; with a medical certificate for physical activity
Exclusion criteria
Exclusion criteria: Patients with untreated/acute deep vein thrombosis; high fever; blood alterations (platelet/hemoglobin below reference); active bleeding; needing a walking aid; difficulty understanding instructions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An improvement in shoulder Range of Motion (ROM) (flexion, abduction, and lateral rotation) is expected, verified by universal goniometry, based on the observation of a statistically significant change (p=0.05) between pre- and post-intervention assessments. | — |
Secondary
| Measure | Time frame |
|---|---|
| A reduction in lymphedema of the upper limb ipsilateral to the surgery is expected, verified by perimetry (arm circumference measurement), based on the observation of a statistically significant reduction (p=0.05) in circumference between pre- and post-intervention assessments. | — |
Countries
Brazil
Contacts
Public ContactRoberto Junior
Universidade do Estado de Mato Grosso - UNEMAT
Outcome results
None listed